Anti-MUC1 Vaccine
Showing 1 - 25 of >10,000
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial in Miami (drug, biological, other)
Completed
- Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancer
- Tadalafil
- +6 more
-
Miami, FloridaUniversity of Miami
Jun 10, 2021
Solid Tumor, Adult Trial in Beijing (Vaccine)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 3, 2023
Advanced Breast Cancer, Breast Tumor Malignant Female Trial in Guangzhou (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)
Completed
- Advanced Breast Cancer
- Breast Neoplasm Malignant Female
- AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Apr 11, 2023
Lung Carcinoma Trial in Rochester, Pittsburgh (Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine)
Active, not recruiting
- Lung Carcinoma
- Laboratory Biomarker Analysis
- MUC1 Peptide-Poly-ICLC Vaccine
-
Rochester, Minnesota
- +1 more
Feb 24, 2022
Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1
Not yet recruiting
- Metastatic Colorectal Cancer
- Retifanlimab
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 4, 2023
Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Refractory Non-Small Cell Lung Cancer
- Daratumumab
- +2 more
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023
Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Falimarev
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 4, 2022
Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))
Completed
- Melanoma (Skin)
- MART-1
- +5 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023
NSCLC, EGFR Gene Mutation Trial in Nanjing (neo-antigen vaccine)
Recruiting
- NSCLC
- EGFR Gene Mutation
- neo-antigen vaccine
-
Nanjing, ChinaThe Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,
Oct 19, 2023
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,
Completed
- Prostatic Neoplasms
- Prostatic Cancer
- ETBX-071; adenoviral PSA vaccine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 28, 2021
Melanoma (Skin) Trial in Tampa (biological, drug, procedure)
Active, not recruiting
- Melanoma (Skin)
- NY-ESO-1 157-165 (165V)
- +5 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023
Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)
Active, not recruiting
- Head and Neck Cancer
- Head and Neck Neoplasms
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)
Withdrawn
- Recurrent Human Papillomavirus Type 16 Associated Cancer
- HPV 16 TA-CIN
-
Birmingham, Alabama
- +1 more
Nov 29, 2022
Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,
Not yet recruiting
- Pancreatic Cancer Metastatic
- Colorectal Cancer Metastatic
- Neoantigen Vaccine with Poly-ICLC adjuvant
- Retifanlimab
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 5, 2022
Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +2 more
- Blood sample collection
- +4 more
-
Besançon, France
- +4 more
Nov 17, 2022
Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide
Not yet recruiting
- Ovarian Cancer Stage IV
- +2 more
- NY-ESO-1 Peptide vaccine
- Nivolumab
-
Washington, District of Columbia
- +2 more
Jul 28, 2022
Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)
Active, not recruiting
- Malignant Neoplasm
- aldesleukin
- +7 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles (UCLA )
Dec 1, 2022
Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)
Not yet recruiting
- Malaria,Falciparum
- MSP3-CRM-Vac4All/ Alhydrogel®
- Anti-Rabies Vaccine
-
Bamako, MaliMalaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023
Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)
Recruiting
- Healthy Adults
- Solo 0.3 group
- +5 more
-
Créteil, France
- +2 more
Sep 9, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Malignant Melanoma, Metastatic, Non Small Cell Lung Cancer Metastatic, Bladder Urothelial Carcinoma, Metastatic Trial in Herlev
Active, not recruiting
- Malignant Melanoma, Metastatic
- +2 more
-
Herlev, Denmark
- +1 more
Jan 10, 2022
Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)
Not yet recruiting
- Lynch Syndrome
- Biopsy
- +5 more
-
Phoenix, Arizona
- +13 more
Sep 16, 2022
Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Neoantigen Dendritic Cell Vaccine
- Nivolumab
-
Singapore, SingaporeNational Cancer Center Singapore
Aug 17, 2022